At Formula Health, our award-winning multidisciplinary medical practice bridges the gap between elite athletic performance and advanced clinical medicine. Founded by the first Human Performance Consultant Osteopath in Formula 1, our clinic integrates cutting-edge medical technology from professional sport with personalised, evidence-based healthcare. Among our comprehensive suite of therapeutic modalities, Mild Hyperbaric Oxygen Therapy (mHBOT) delivered at 1.5 ATA (Atmospheres Absolute) represents a cornerstone intervention for accelerated tissue healing, metabolic optimisation, and systemic resilience.

Understanding the physiological mechanics of 1.5 ATA hyperbaric protocols enables clinicians and patients to harness targeted hyperoxia for specific clinical objectives, ranging from post-surgical rehabilitation to mitochondrial biogenesis.

The Physiological Mechanics of 1.5 ATA Hyperbaric Oxygen Therapy

Hyperbaric oxygen therapy involves breathing purified oxygen within a pressurised environment. At normal atmospheric pressure (1 ATA), human blood plasma carries a limited quantity of oxygen bound primarily to haemoglobin. When atmospheric pressure is elevated to 1.5 ATA: increasing ambient pressure by 50% above sea level: Henry’s Law dictates that the physical dissolution of gases in liquids increases proportionally.

This mechanism supersaturates the blood plasma with dissolved oxygen, elevating plasma oxygen concentrations significantly. Consequently, oxygen diffuses up to four times further into ischaemic, inflamed, or traumatised tissues than under normal physiological conditions. This process occurs independently of red blood cell transport, bathing compromised cellular environments in vital oxygen necessary for cellular respiration and tissue regeneration.

1. Post-Surgical Recovery: Accelerating Wound Healing and Reducing Oedema

Surgical trauma invariably induces localised hypoxia, capillary disruption, and significant inflammatory oedema. Deprived of adequate oxygen, fibroblast proliferation, collagen synthesis, and angiogenesis stall, prolonging recovery times and increasing the risk of fibrotic scarring or secondary complications.

Clinical Protocol and Mechanism

At 1.5 ATA, hyperbaric oxygen protocols stimulate post-surgical recovery through several distinct biological pathways:

• Angiogenesis Stimulation: Hyperoxia upregulates vascular endothelial growth factor (VEGF) gene expression, triggering the formation of new capillary networks in healing tissue beds.
• Fibroblast Activation: Collagen matrix deposition relies heavily on oxygen-dependent hydroxylation enzymes (prolyl and lysyl hydroxylase). Elevated plasma oxygen accelerates tensile strength development in surgical incisions and grafts.
• Oedema Reduction: High hydrostatic pressure combined with hyperoxia induces localized vasoconstriction, successfully shrinking interstitial fluid accumulation and reducing post-operative swelling without compromising tissue perfusion.

Clinical application typically involves 60- to 90-minute sessions administered daily or five days per week over a targeted course of 20 to 40 treatments, depending on the complexity of the surgical intervention.

2. Adjunctive Support During Cancer Therapy: Cellular Resilience and Quality of Life

As an adjunctive modality, Hyperbaric Oxygen Therapy is increasingly evaluated for its capacity to support patients undergoing conventional oncology treatments, such as radiotherapy and chemotherapy. It must be strictly framed as supportive and adjunctive care designed to enhance quality of life and mitigate treatment toxicities rather than act as a primary oncologic treatment.

Clinical Protocol and Mechanism

Radiation therapy and certain chemotherapeutic agents induce collateral damage to healthy tissues surrounding neoplastic sites, often resulting in chronic radiation tissue injury, fatigue, and mucosal inflammation.

• Mitigating Radiation Injury: Intermittent hyperoxia at mild pressures stimulates neovascularisation in hypoxic, radiation-damaged tissue, mitigating late radiation fibrosis and accelerating mucosal repair.
• Cellular Resilience: By modulating oxidative stress pathways and upregulating endogenous antioxidant defences (such as superoxide dismutase and glutathione peroxidase), 1.5 ATA protocols protect non-cancerous somatic cells from chemotherapy-induced systemic toxicity.
• Fatigue Reduction: Oncology patients frequently experience severe treatment-related fatigue linked to mitochondrial suppression. Restoring cellular oxygen utilisation improves overall energy metabolism and physical endurance during arduous treatment schedules.

Protocols in this domain require meticulous coordination with treating oncologists, typically utilising gentle 1.5 ATA sessions to support systemic recovery and preserve functional capacity.

3. Cellular Energy and Mitochondrial Health: Upregulating ATP Production

Mitochondria generate over 90% of cellular adenosine triphosphate (ATP). When subjected to chronic inflammation, physiological stress, or aging, mitochondrial electron transport chain efficiency declines, leading to cellular energy crises and persistent fatigue.

Clinical Protocol and Mechanism

Intermittent exposure to 1.5 ATA hyperbaric oxygen acts as a powerful metabolic signal that directly targets mitochondrial function:

• ATP Upregulation: Increased oxygen availability relieves bottlenecks in cytochrome c oxidase (Complex IV) of the mitochondrial respiratory chain, instantly augmenting oxidative phosphorylation and ATP synthesis.
• Mitochondrial Biogenesis: Research indicates that mild hyperbaric exposure activates peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), the master regulator of mitochondrial biogenesis, prompting the replication of healthy, functional mitochondria.
• Combatting Oxidative Fatigue: While high-pressure hyperbaric protocols can induce excessive reactive oxygen species (ROS), 1.5 ATA sits within an optimal therapeutic window that stimulates hormetic adaptive antioxidant responses without overwhelming cellular redox balance.

Standard protocols targeting metabolic revitalisation and neurocognitive recovery (such as those studied in mild traumatic brain injury trials) typically employ 60-minute daily sessions at 1.4 to 1.5 ATA for 40 consecutive sessions.

4. Immune System Resilience and Modulation

Immune competence depends heavily on the metabolic efficiency and microenvironmental oxygenation of leukocytes, macrophages, and natural killer cells. Hypoxic tissue microenvironments impair neutrophil oxidative burst capabilities, limiting the body's natural defense against pathogens.

Clinical Protocol and Mechanism

Oxygen acts as a potent immunomodulatory agent at 1.5 ATA:

• Enhanced Leukocyte Function: Neutrophils require adequate oxygen tensions to generate superoxide radicals via NADPH oxidase to neutralize ingested bacteria. Mild hyperoxia restores this enzymatic capacity in compromised tissues.
• Inflammatory Cytokine Regulation: HBOT downregulates pro-inflammatory cytokines (such as TNF-alpha and IL-6) while promoting anti-inflammatory signaling pathways, helping to resolve chronic, low-grade systemic inflammation.
• Bacteriostatic Action: Elevated tissue oxygen tensions exert direct bacteriostatic and bactericidal effects on anaerobic and microaerophilic pathogens, bolstering host defence mechanisms.

The Formula Health Patient Experience: Our 1.5 ATA Chamber

At Formula Health, we recognise that clinical efficacy must be matched by patient comfort and safety. Our protocols are delivered within our advanced 1.5 ATA soft-shell hyperbaric chambers, specifically engineered for optimal therapeutic pressure while maintaining a spacious, calming environment.

Each unit is equipped with a comfortable reclining chair, allowing patients to relax, read, or work during their 60-minute session. This patient-centric design removes the claustrophobia often associated with rigid, clinical monoplace tubes, ensuring a seamless integration into personalised health optimisation plans.

Scientific References

1. Efrati, S., et al. (2013). Hyperbaric oxygen therapy can induce neuroplasticity and improve cognitive function of patients with persistent post-concussion syndrome. PLoS ONE, 8(9), e79995.
2. Hadanny, A., & Efrati, S. (2020). The Hyperbaric Oxygen Therapy Protocol Can Induce Angiogenesis and Regeneration of Nerve Fibers in Patients With Chronic Traumatic Brain Injury. Frontiers in Human Neuroscience, 14, 508.
3. Thom, S. R. (2009). Oxidative stress is averted by interrupting hyperbaric oxygen exposures with air breaks. Journal of Applied Physiology, 106(6), 1885-1892.
4. Rockswold, S. B., et al. (2013). A prospective, randomized phase II clinical trial to evaluate the effect of combined hyperbaric and normobaric hyperoxia on cerebral metabolism, intracranial pressure, and oxygen toxicity in severe traumatic brain injury. Journal of Neurosurgery, 118(6), 1317-1328.
5. Tibbles, P. M., & Edelsberg, J. S. (1996). Hyperbaric-oxygen therapy. The New England Journal of Medicine, 334(25), 1642-1648.

To discover how our multidisciplinary team can integrate Advanced Integrated Medicine and Hyperbaric Oxygen Therapy into your personal health journey, explore our services or schedule a consultation with our specialists.